Sense and Treat

Pfizer’s Obesity Push: Can Berobenatide Take Market Share?

By healthylife7August 19, 20260

The global obesity market is emerging as one of the largest growth opportunities in pharmaceuticals. The market is projected to grow dramatically, reaching nearly $114 billion by 2030 Eli Lilly’s LLY Zepbound and Novo Nordisk’s NVO Wegovy are the most popular GLP-1 drugs used to treat obesity

What's Hot

Pfizer’s Obesity Push: Can Berobenatide Take Market Share?

Wilmington honors its own: Be there for upcoming park, gym renaming ceremonies and more

Just 1 Sugary Drink a Day More Than Doubles Risk of Stomach Cancer

Vibration plates show promise for people with lymphedema

BioMarin to acquire Alesta Therapeutics for $275 million for potential rare bone disease treatment

Mad cow disease case confirmed at farm in Dumfries and Galloway

Pfizer’s Obesity Push: Can Berobenatide Take Market Share?

Wilmington honors its own: Be there for upcoming park, gym renaming ceremonies and more

Just 1 Sugary Drink a Day More Than Doubles Risk of Stomach Cancer

A real-world study of Oregon’s nonmedical psilocybin program shows promise

Opinion: The FDA must put biotech at its center or continue to cede early research to China

Inside Elevance’s digital chronic disease management strategy

Best, Worst States For Well

What do the Middle Ages tell us about mental health then and now? VCU historian Leigh Ann Craig has answers

Fitness

Pfizer’s Obesity Push: Can Berobenatide Take Market Share?

Wilmington honors its own: Be there for upcoming park, gym renaming ceremonies and more

Just 1 Sugary Drink a Day More Than Doubles Risk of Stomach Cancer

Health

Opinion: The FDA must put biotech at its center or continue to cede early research to China

Inside Elevance’s digital chronic disease management strategy

Best, Worst States For Well

Subscribe to Updates

What's Hot

Sense and Treat

Related Posts